Folyóiratcikkek tallózása szerző szerint "Hadaschik, B"

A találatok rendezése: Rendezés: Találatok:

  • Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer 
    Szarvas, Tibor; Sevcenco, S; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Kubik, András; Romics, Miklós; Kovalszky, Ilona; Reis, H; Hadaschik, B; Shariat, SF; Kramer, G (2018)
    OBJECTIVES: Docetaxel chemotherapy is a standard treatment for castration-resistant prostate cancer (CRPC). Rapidly expanding treatment options for CRPC provide reasonable alternatives for those who are resistant to ...
  • MMP-7, sFas and FasL serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer 
    Szarvas, Tibor; Sevcenco, S; Módos, Orsolya; Keresztes, Dávid; Nyirády, Péter; Csizmarik, Anita; Ristl, R; Puhr, M; Hoffmann, MJ; Niedworok, C; Hadaschik, B; Maj-Hes, A; Shariat, SF; Kramer, G (2018)
    PURPOSE: To assess the predictive value of pre-chemotherapy MMP-7, sFas, FasL serum levels as well as their changes during therapy. PATIENTS AND METHODS: Serum levels of MMP-7, Fas and FasL were determined by ELISA in 96 ...
  • Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas 
    Reis, H; van der Vos, KE; Niedworok, C; Herold, T; Módos, Orsolya; Szendrői, Attila; Hager, T; Ingenwerth, M; Vis, DJ; Behrendt, MA; de Jong, J; van der Heijden, MS; Peyronnet, B; Mathieu, R; Wiesweg, M; Ablat, J; Okon, K; Tolkach, Y; Keresztes, D; Nagy, N; Bremmer, F; Gaisa, NT; Chlosta, P; Kriegsmann, J; Kovalszky, Ilona; Timár, József; Kristiansen, G; Radzun, HJ; Knuchel, R; Schuler, M; Black, P; Rubben, H; Hadaschik, B; Schmid, KW; van Rhijn, BWG; Nyirády, Péter; Szarvas, Tibor (2018)
    Urachal cancer (UrC) is a rare but aggressive malignancy often diagnosed in advanced stages requiring systemic treatment. Although cytotoxic chemotherapy is of limited effectiveness, prospective clinical studies can hardly ...